| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-07 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-07 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-07 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-07 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |